Treatment with senolytic drugs ameliorates steroid-induced osteonecrosis of the femoral head by inhibiting osteoclastogenesis.
Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining.
Rapid Discovery of Potential Drugs for Osteonecrosis of Femoral Head Based on Gene Expression Omnibus Database and Connectivity Map.
Exogenous melatonin ameliorates steroid-induced osteonecrosis of the femoral head by modulating ferroptosis through GDF15-mediated signaling.
Li W, Li W, Zhang W, Wang H, Yu L, Yang P, Qin Y, Gan M, Yang X, Huang L, Hao Y, Geng D.
Stem Cell Res Ther. 2023 Jul 3;14(1):171. doi: 10.1186/s13287-023-03371-y.
Advances in experimental models of osteonecrosis of the femoral head.
Li Z, Shao W, Lv X, Wang B, Han L, Gong S, Wang P, Feng Y.
J Orthop Translat. 2023 Feb 3;39:88-99. doi: 10.1016/j.jot.2023.01.003. eCollection 2023 Mar.
Research Progress on Exosomes in Osteonecrosis of the Femoral Head.
Liu X, Wang C, Meng H, Liao S, Zhang J, Guan Y, Tian H, Peng J.
Orthop Surg. 2022 Sep;14(9):1951-1957. doi: 10.1111/os.13393. Epub 2022 Aug 4.
Engineered Exosome-Functionalized Extracellular Matrix-Mimicking Hydrogel for Promoting Bone Repair in Glucocorticoid-Induced Osteonecrosis of the Femoral Head.
Chen C, Fu L, Luo Y, Zeng W, Qi X, Wei Y, Chen L, Zhao X, Li D, Tian M, Kang P.
ACS Appl Mater Interfaces. 2023 Jun 21;15(24):28891-28906. doi: 10.1021/acsami.3c01539. Epub 2023 Jun 12.
Polydatin promotes the osteogenic differentiation of human bone mesenchymal stem cells by activating the BMP2-Wnt/β-catenin signaling pathway.
Chen XJ, Shen YS, He MC, Yang F, Yang P, Pang FX, He W, Cao YM, Wei QS.
Biomed Pharmacother. 2019 Apr;112:108746. doi: 10.1016/j.biopha.2019.108746. Epub 2019 Mar 2.
IRF8 and its related molecules as potential diagnostic biomarkers or therapeutic candidates and immune cell infiltration characteristics in steroid-induced osteonecrosis of the femoral head.
Liang XZ, Liu XC, Li S, Wen MT, Chen YR, Luo D, Xu B, Li NH, Li G.
J Orthop Surg Res. 2023 Jan 10;18(1):27. doi: 10.1186/s13018-022-03381-1.
Selenium nanoparticles/carboxymethyl chitosan/alginate antioxidant hydrogel for treating steroid-induced osteonecrosis of the femoral head.
Liu C, Wang C, Liu Y, Huang J, Xu W, Li J, Wang Y, Xu Y, Zhu L, Xu H.
Int J Pharm. 2024 Mar 25;653:123929. doi: 10.1016/j.ijpharm.2024.123929. Epub 2024 Feb 20.
The pathogenesis of steroid-induced osteonecrosis of the femoral head: A systematic review of the literature.
Wang A, Ren M, Wang J.
Gene. 2018 Sep 10;671:103-109. doi: 10.1016/j.gene.2018.05.091. Epub 2018 May 30.
Identification of microtubule-associated biomarker using machine learning methods in osteonecrosis of the femoral head and osteosarcoma.
Yang S, Zhao Y, Tan Y, Zheng C.
Heliyon. 2024 May 23;10(11):e31853. doi: 10.1016/j.heliyon.2024.e31853. eCollection 2024 Jun 15.
Identification and validation of endoplasmic reticulum stress-related genes in patients with steroid-induced osteonecrosis of the femoral head.
Wu T, Shi W, Zhou Y, Guo S, Tian H, Jiang Y, Li W, Wang Y, Li T.
Sci Rep. 2024 Sep 16;14(1):21634. doi: 10.1038/s41598-024-72941-8.
